文献速递临床免疫临床微生物

改良两步法酶免疫分析在新斯科舍省莱姆病血清学诊断中的性能评估

Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.
PubMed 文献 · J Clin Microbiol · 2020-06-24

该研究回顾性分析了加拿大新斯科舍省2011至2014年10253份莱姆病血清学检测标本,评估采用全细胞EIA联合C6 EIA的改良两步法(MTTT)相比标准两步法(STTT,EIA联合免疫印迹)的诊断性能。结果显示MTTT检测出多25%的早期感染,特异性为99.56%(99.41至99.68%),与STTT相近,为加拿大首个证实MTTT可提高早期伯氏疏螺旋体感染敏感性的数据。

要点

  • MTTT(全细胞EIA联合C6 EIA)较STTT多检出25%的早期莱姆病感染。
  • MTTT特异性达99.56%(99.41至99.68%),与基于免疫印迹的STTT相似。
  • 447例阳性患者中271份病历可回顾,227例被归类为莱姆病患者。

核心结论

  • 采用全细胞超声处理EIA联合C6 EIA的MTTT方案可提高早期伯氏疏螺旋体感染的检出敏感性,且特异性与使用免疫印迹的STTT相似。

研究设计与样本

  • 回顾性研究,2011至2014年加拿大新斯科舍省送检的10253份莱姆病血清学标本。
  • 对全细胞EIA和C6 EIA阳性的患者进行病历回顾,共447例阳性患者中271份病历可审查。

主要发现

  • 10253份标本中9806份(95.6%)莱姆病血清学阴性。
  • 447例阳性患者中271份病历可回顾,227例被归类为莱姆病患者。
  • MTTT算法检测出多25%的早期感染,特异性为99.56%(99.41至99.68%),与STTT相比。

关键数值与推荐

  • 患者分类为莱姆病的条件:STTT阳性、或STTT阴性但症状符合莱姆病、或配对标本显示血清学转换。

临床怎么用

  • 在莱姆病高流行区,可考虑采用全细胞EIA联合C6 EIA的MTTT方案替代基于免疫印迹的STTT,以提高早期感染检出率并保持高特异性。

局限性

  • 回顾性设计,仅271份阳性患者病历可审查,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Compared to the standard two-tiered testing (STTT) algorithm for Lyme disease serology using an enzyme immunoassay (EIA) followed by Western blotting, data from the United States suggest that a modified two-tiered testing (MTTT) algorithm employing two EIAs has improved sensitivity to detect early localized Borrelia burgdorferi infections without compromising specificity. From 2011 to 2014, in the Canadian province of Nova Scotia, where Lyme disease is hyperendemic, sera submitted for Lyme disease testing were subjected to a whole-cell EIA, followed by C6 EIA and subsequently IgM and/or IgG immunoblots on sera with EIA-positive or equivocal results. Here, we evaluate the effectiveness of the MTTT algorithm compared to the STTT approach in a Nova Scotian population. Retrospective chart reviews were performed on patients testing positive with the whole-cell and C6 EIAs (i.e., the MTTT algorithm). Patients were classified as having Lyme disease if they had a positive STTT result, a negative STTT result but symptoms consistent with Lyme disease, or evidence of seroconversion on paired specimens. Of the 10,253 specimens tested for Lyme disease serology, 9,806 (95.6%) were negative. Of 447 patients who tested positive, 271 charts were available for review, and 227 were classified as patients with Lyme disease. The MTTT algorithm detected 25% more early infections with a specificity of 99.56% (99.41 to 99.68%) compared to the STTT. These are the first Canadian data to show that serology using a whole-cell sonicate EIA followed by a C6 EIA (MTTT) had improved sensitivity for detecting early B. burgdorferi infection with specificity similar to that of two-tiered testing using Western blots.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Davis IRC, McNeil SA, Allen W, et al. Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia. J Clin Microbiol. 2020. PMID: 32321781. doi:10.1128/JCM.01841-19

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。